Back to today’s briefing

Story perspectives

Illumina to Acquire SomaLogic for $425 Million Deal

6/24/2025

45 4

Summary

Story summary

Illumina is set to acquire SomaLogic from Standard BioTools for a staggering $425 million, comprising $350 million in cash and $75 million tied to performance milestones. This strategic move will bolster Illumina's foothold in the proteomics market and propel its multiomics strategy forward, with the deal anticipated to finalize in early 2026.

History

Historical Context

The Human Genome Project, completed in 2012 at a cost of approximately $3 billion, revolutionized genomics by mapping the entire human genome. This milestone spurred advancements in biotechnology, leading to significant acquisitions like Illumina's purchase of SomaLogic for $425 million, reflecting a trend towards integrating multiomics strategies that enhance personalized medicine and transform patient care methodologies.

1 of 2

Story summary

Illumina is set to acquire SomaLogic from Standard BioTools for a staggering $425 million, comprising $350 million in cash and $75 million tied to performance milestones. This strategic move will bolster Illumina's foothold in the proteomics market and propel its multiomics strategy forward, with the deal anticipated to finalize in early 2026.

1 / 2